Pharmacology · Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics)

A 55-year-old man started on sotalol for paroxysmal atrial fibrillation develops syncope three days after initiation. ECG shows polymorphic ventricular tachycardia with a twisting QRS axis. Which property of sotalol most directly explains this event?

  • A Strong sodium channel blockade causing wide QRS complexes
  • B Selective beta-1 antagonism producing severe bradycardia
  • C Dose-related prolongation of the action potential duration via IKr blockade
  • D Calcium channel blockade at the AV node
Correct answer: C. Dose-related prolongation of the action potential duration via IKr blockade

Explanation

Sotalol combines nonspecific beta-blockade with class III activity by blocking the rapid component of the delayed rectifier potassium current (IKr). This prolongs repolarization and the QT interval in a dose-dependent manner, creating a substrate for torsades de pointes, particularly early after initiation or after dose escalation. It has no meaningful sodium channel blocking activity, ruling out option A. Beta-blockade slows sinus rate but causes bradycardia, not polymorphic VT, and sotalol lacks calcium channel blocking properties.

Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs

See all Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs →